Pricing Log in Create free account

Alector, Inc. (ALEC) vs Evommune Inc. (EVMN)

Alector, Inc. and Evommune Inc. are both Biotechnology companies. Alector, Inc. and Evommune Inc. are of similar size ($215.2M and $213.3M). Evommune Inc. has the higher net margin (0.00% vs −850.1%) and the lower return on invested capital (−82.5% vs 0.00%). Across the 12 metrics below, Evommune Inc. leads on 7 and Alector, Inc. on 5.

Valuation

Metric ALEC EVMN Biotechnology median
P/E n/m n/m 8.42
P/S 15.32 n/m 10.01
P/B n/m 0.77 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 4.17 n/m 9.41
Earnings yield (57.59%) (186.00%) (31.85%)
Free cash flow yield (74.56%) (34.84%) (24.58%)

Profitability

Metric ALEC EVMN Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (912.40%) 0.00% 0.00%
Net margin (850.13%) 0.00% 0.00%
Free cash flow margin (1,142.55%) 0.00% 0.00%
Return on equity (385.11%) (141.99%) (56.36%)
Return on assets (42.15%) (62.71%) (48.04%)
Return on invested capital 0.00% (82.46%) 0.00%

Growth

Metric ALEC EVMN Biotechnology median
Revenue growth (TTM) (82.91%) — 6.02%
EPS growth (last fiscal year) (13.01%) 75.23% 30.26%
Revenue growth, 5-year CAGR (0.05%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ALEC EVMN Biotechnology median
Debt to equity (0.99) 0.00 0.00
Current ratio 5.26 11.68 4.72
Net debt to EBITDA 1.61 1.87 0.96

Dividend

Metric ALEC EVMN Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ALEC EVMN Biotechnology median
Market cap 213.27m 215.22m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack